Clinical Trial Update: Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing combination chemotherapy with hormone therapy in recurrent stage III/IV endometrial cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 3 | Status: TERMINATED